CompletedEarly Phase 1NCT04408092

Study of the Effect of GM-CSF on Macrophages in Ependymoma

Studying Ependymoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Colorado, Denver
Principal Investigator
Nicholas Foreman, MD
University of Colorado, Denver
Intervention
Granulocyte Macrophage Colony Stimulation Factor(drug)
Enrollment
6 enrolled
Eligibility
21 years · All sexes
Timeline
20132023

Study locations (2)

Collaborators

National Cancer Institute (NCI) · Children's Hospital Colorado

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04408092 on ClinicalTrials.gov

Other trials for Ependymoma

Additional recruiting or active studies for the same condition.

See all trials for Ependymoma

← Back to all trials